CVAC
Price
$5.46
Change
+$0.02 (+0.37%)
Updated
Jul 25 closing price
Capitalization
1.23B
18 days until earnings call
HNSBF
Price
$2.74
Change
-$0.26 (-8.67%)
Updated
Jul 17 closing price
Capitalization
233.17M
Interact to see
Advertisement

CVAC vs HNSBF

Header iconCVAC vs HNSBF Comparison
Open Charts CVAC vs HNSBFBanner chart's image
CureVac
Price$5.46
Change+$0.02 (+0.37%)
Volume$560.69K
Capitalization1.23B
Hansa Medical AB
Price$2.74
Change-$0.26 (-8.67%)
Volume$7.12K
Capitalization233.17M
CVAC vs HNSBF Comparison Chart in %
Loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HNSBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVAC vs. HNSBF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVAC is a StrongBuy and HNSBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (CVAC: $5.46 vs. HNSBF: $2.74)
Brand notoriety: CVAC and HNSBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVAC: 39% vs. HNSBF: 465%
Market capitalization -- CVAC: $1.23B vs. HNSBF: $233.17M
CVAC [@Biotechnology] is valued at $1.23B. HNSBF’s [@Biotechnology] market capitalization is $233.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVAC’s FA Score shows that 1 FA rating(s) are green whileHNSBF’s FA Score has 0 green FA rating(s).

  • CVAC’s FA Score: 1 green, 4 red.
  • HNSBF’s FA Score: 0 green, 5 red.
According to our system of comparison, CVAC is a better buy in the long-term than HNSBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVAC’s TA Score shows that 4 TA indicator(s) are bullish while HNSBF’s TA Score has 1 bullish TA indicator(s).

  • CVAC’s TA Score: 4 bullish, 4 bearish.
  • HNSBF’s TA Score: 1 bullish, 4 bearish.
According to our system of comparison, CVAC is a better buy in the short-term than HNSBF.

Price Growth

CVAC (@Biotechnology) experienced а +1.30% price change this week, while HNSBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

CVAC is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVAC($1.23B) has a higher market cap than HNSBF($233M). CVAC YTD gains are higher at: 60.117 vs. HNSBF (-8.667). CVAC has higher annual earnings (EBITDA): 228M vs. HNSBF (-523.23M). CVAC has more cash in the bank: 442M vs. HNSBF (250M). CVAC has less debt than HNSBF: CVAC (37.4M) vs HNSBF (1.02B). CVAC has higher revenues than HNSBF: CVAC (524M) vs HNSBF (182M).
CVACHNSBFCVAC / HNSBF
Capitalization1.23B233M527%
EBITDA228M-523.23M-44%
Gain YTD60.117-8.667-694%
P/E Ratio5.80N/A-
Revenue524M182M288%
Total Cash442M250M177%
Total Debt37.4M1.02B4%
FUNDAMENTALS RATINGS
HNSBF: Fundamental Ratings
HNSBF
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVACHNSBF
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 3 days ago
29%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
29%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
42%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
11%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
25%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HNSBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DMIDX29.070.26
+0.90%
BNY Mellon MidCap Index I
QLSGX29.560.24
+0.82%
Federated Hermes MDT Small Cap Growth R6
CIGEX19.980.07
+0.35%
Calamos Global Equity I
PRMSX38.60-0.11
-0.28%
T. Rowe Price Emerging Markets Stock
RALIX10.74-0.03
-0.28%
Lazard Real Assets Instl

HNSBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HNSBF has been loosely correlated with ENSC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if HNSBF jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSBF
1D Price
Change %
HNSBF100%
N/A
ENSC - HNSBF
33%
Loosely correlated
+1.82%
CVAC - HNSBF
33%
Poorly correlated
+0.37%
MLLCF - HNSBF
27%
Poorly correlated
N/A
GNPX - HNSBF
25%
Poorly correlated
-4.59%
GRI - HNSBF
25%
Poorly correlated
+1.02%
More